OFDT Documentation

  • Recherche
    • Recherche simple
    • Périodiques
    • Publications OFDT
    • Textes législatifs
    • Nos dernières publications
  • Sélections
    • Usages de drogues à l’adolescence
    • Usages de drogues féminins
    • Drogues et sécurité routière
    • Addictions en milieu professionnel
    • Addictions en milieu carcéral
  • À propos
    • Présentation
    • Contact
Aide

Rechercher

Aide

Recherche avancée

Périodiques

Portail documentaire

  • A-
  • A
  • A+

Site OFDT

Historique

Accès réservé à l'OFDT et ses partenaires



Mot de passe oublié ?
  • Recherche
    • Recherche simple
    • Périodiques
    • Publications OFDT
    • Textes législatifs
    • Nos dernières publications
  • Sélections
    • Usages de drogues à l’adolescence
    • Usages de drogues féminins
    • Drogues et sécurité routière
    • Addictions en milieu professionnel
    • Addictions en milieu carcéral
  • À propos
    • Présentation
    • Contact

Rechercher

Aide

Recherche avancée

Périodiques

  1. Accueil
  2. Retour
Clinical Infectious Diseases, Vol.57, Suppl.2 - August 2013 - Prevention and management of hepatitis C virus infection among people who inject drugs: Moving the agenda forward
Ajouter à la sélection Ajouter à la sélection
Bulletin de Périodique
Clinical Infectious Diseases , Vol.57, Suppl.2 - August 2013 - Prevention and management of hepatitis C virus infection among people who inject drugs: Moving the agenda forward
Paru le : 15/08/2013
Année : 2013
Sous-type de document : N° spécial de revue / Special issue of a journal
Langue(s) : Anglais
Domaine : Drogues illicites / Illicit drugs
Discipline : MAL (Maladies infectieuses / Infectious diseases)
Thésaurus mots-clés
HEPATITE

Dépouillements

Ajouter le résultat à votre sélection
Moving the agenda forward: the prevention and management of hepatitis C virus infection among people who inject drugs

Moving the agenda forward: the prevention and management of hepatitis C virus infection among people who inject drugs

J. GREBELY ; P. BRUGGMANN ; M. BACKMUND ; G. J. DORE | 2013
Dans Clinical Infectious Diseases (Vol.57, Suppl.2, August 2013) Article : Périodique
The majority of hepatitis C virus (HCV) occurs among people who inject drugs (PWID), and the burden of HCV-related liver disease is still increasing. HCV treatment is safe and effective among PWID, and international guidelines encourage HCV trea[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention

Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention

K. PAGE ; M. D. MORRIS ; J. A. HAHN ; L. MAHER ; M. PRINS | 2013
Dans Clinical Infectious Diseases (Vol.57, Suppl.2, August 2013) Article : Périodique
The hepatitis C virus (HCV) virus epidemic is ongoing in the United States and globally. Incidence rates remain high, especially in young adult injection drug users. New outbreaks of HCV in the United States among young adults, in predominantly [...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy

Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy

N. K. MARTIN ; M. HICKMAN ; S. J. HUTCHINSON ; D. J. GOLDBERG ; P. VICKERMAN | 2013
Dans Clinical Infectious Diseases (Vol.57, Suppl.2, August 2013) Article : Périodique
BACKGROUND: Interventions such as opiate substitution therapy (OST) and high-coverage needle and syringe programs (HCNSP) cannot substantially reduce hepatitis C virus (HCV) prevalence among people who inject drugs (PWID). HCV antiviral treatmen[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all

Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all

P. BRUGGMANN ; A. H. LITWIN | 2013
Dans Clinical Infectious Diseases (Vol.57, Suppl.2, August 2013) Article : Périodique
One of the major obstacles to hepatitis C virus (HCV) care in people who inject drugs (PWID) is the lack of treatment settings that are suitably adapted for the needs of this vulnerable population. Nevertheless, HCV treatment has been delivered [...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study

Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study

M. ALAVI ; J. GREBELY ; M. MICALLEF ; A. J. DUNLOP ; A. C. BALCOMB ; C. A. DAY ; C. TRELOAR ; N. BATH ; P. S. HABER ; G. J. DORE | 2013
Dans Clinical Infectious Diseases (Vol.57, Suppl.2, August 2013) Article : Périodique
BACKGROUND: Access to hepatitis C virus (HCV) treatment remains extremely limited among people who inject drugs (PWID). HCV assessment and treatment was evaluated through an innovative model for the provision of HCV care among PWID with chronic [...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis

Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis

E. ASPINALL ; S. CORSON ; J. S. DOYLE ; J. GREBELY ; S. J. HUTCHINSON ; G. J. DORE ; D. J. GOLDBERG ; M. E. HELLARD | 2013
Dans Clinical Infectious Diseases (Vol.57, Suppl.2, August 2013) Article : Périodique
BACKGROUND: Although guidelines recommend that people who inject drugs (PWID) should not be excluded from hepatitis C (HCV) treatment, some services remain reluctant to treat PWID. The aim of this review was to investigate sustained virologic re[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Hepatitis C virus reinfection following treatment among people who use drugs

Hepatitis C virus reinfection following treatment among people who use drugs

B. P. GRADY ; J. SCHINKEL ; X. V. THOMAS ; O. DALGARD | 2013
Dans Clinical Infectious Diseases (Vol.57, Suppl.2, August 2013) Article : Périodique
Most new cases of hepatitis C virus (HCV) infections in the developed world are associated with injection drug use. However, treatment for people who inject drugs (PWID) is controversial, as successful treatment risks being followed by new infec[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Drug-drug interactions in the treatment of HCV among people who inject drugs

Drug-drug interactions in the treatment of HCV among people who inject drugs

S. MAUSS ; H. KLINKER | 2013
Dans Clinical Infectious Diseases (Vol.57, Suppl.2, August 2013) Article : Périodique
Boceprevir and telaprevir are inhibitors and substrates of the cytochrome P450 3A4 family. With the use of these HCV protease inhibitors as part of standard therapy for chronic hepatitis C genotype 1 infection, drug-drug interactions with multip[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Recommendations for the management of hepatitis C virus infection among people who inject drugs

Recommendations for the management of hepatitis C virus infection among people who inject drugs

G. ROBAEYS ; J. GREBELY ; S. MAUSS ; P. BRUGGMANN ; J. MOUSSALLI ; A. DE GOTTARDI ; T. SWAN ; A. ARAIN ; A. KAUTZ ; H. STÖVER ; H. WEDEMEYER ; M. SCHAEFER ; L. TAYLOR ; M. BACKMUND ; O. DALGARD ; M. PRINS ; G. J. DORE | 2013
Dans Clinical Infectious Diseases (Vol.57, Suppl.2, August 2013) Article : Périodique
In the developed world, the majority of new and existing hepatitis C virus (HCV) infections occur among people who inject drugs (PWID). The burden of HCV-related liver disease in this group is increasing, but treatment uptake among PWID remains [...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection

Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection

S. CRAWFORD ; N. BATH | 2013
Dans Clinical Infectious Diseases (Vol.57, Suppl.2, August 2013) Article : Périodique
People who inject drugs (PWID) are the group most affected by HCV; however, treatment uptake has been low. Engagement between PWID and healthcare workers has been characterized by mistrust and discrimination. Peer support for HCV is one way to o[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Nouvelle recherche Votre compte

Contact

OFDT

69 rue de Varenne
75700 PARIS

Tel : (+33) 01 41 62 77 16

Accès rapides

  • L’établissement
  • Les partenaires
  • La lettre d’information

Avertissement

Toute inclusion dans la base documentaire ne vaut pas crédit scientifique de l'OFDT

Contact

OFDT

69 rue de Varenne
75700 PARIS

Tel : (+33) 01 41 62 77 16

Accès rapides

  • L’établissement
  • Les partenaires
  • La lettre d’information

Avertissement

Toute inclusion dans la base documentaire ne vaut pas crédit scientifique de l'OFDT

Suivez-nous

  • Traitement des données personnelles
  • Mentions légales
  • Plan du site